A method for pharmaceutical-origin micropollutants removal from wastewater

Summary of the technology

The method is a completely biological process for eliminating pharmaceutical micropollutants in wastewater. The process includes:
-Screening as pre-treatment process
-Moving-bed membrane bioreactor (MB-MBR) populated by a first microbial consortium
-Biofiltration tank comprising biologically activated carbon (second microbial consortium)

Details of the Technology Offer

Background:The presence of micropollutants in wastewater are becoming a threat to aquatic ecosystems and to the safety of drinking water resources. Unfortunately, micropollutants are only partially removed by conventional bioprocesses in sewage treatment works and so they are released in surface water. Pharmaceuticals and endocrine disruptors can be harmful for the animals and negative impacts have already been observed in polar bears and fishes. The current state of the art technologies are physico-chemical processes such as rapid gravity filter (activated carbon), UV and/or ozone treatment. Those treatment are costly and not adapted to water with a high organic content such as treated wastewater.

Benefits:

The main benefits of our method are:

  • Low cost- our method aims to reduce operational cost, especially energy consumption
  • 100% biological treatment
  • Reduction of fouling due to the removal of the reverse osmosis step and the loss of activated carbon
  • Compact system
  • Applications:
  • Wastewater Treatment Plants operators active in the medical sector (hospitals, clinics), focusing on pharmaceutical-origin micropollutants reduction
  • Manufacturers and designers of wastewater treatment systems targeting pharmaceutical removal and/or reduction of water toxicity from pharmaceutical-origin micropollutants
  • Incorporation in decentralised wastewater treatment process targeting health care infrastructures (hospitals, retirement houses…) where antibiotics are intensively used
  • IP Status:Patent has been already granted (AT, CH, DE, GB, IE); and pending at MA.
  • Companies of interest:

  • Wastewater Treatment plant operators,
  • Wastewater Treatment plants manufacturers and designers
  • Industrial partners: Sanofi, GSK, Suez, Veolia, Thames water...

Desired business relationship

Technology development

Other : Licensing

Related Keywords

  • Industrial manufacturing, Material and Transport Technologies
  • Industrial Manufacture
  • Protecting Man and Environment
  • Water Management
  • Drinking Water
  • Industrial Water Treatment
  • Municipal Water Treatment
  • Sustainability
  • Water treatment equipment and waste disposal systems

About Luxembourg Institute of Science and Technology (LIST)

The Luxembourg Institute of Science and Technology (LIST) is a mission-driven Research and Technology Organisation (RTO) active in the fields of materials, environment and IT.
LIST develops competitive and market-oriented product/service prototypes for public and private stakeholders, and works across the entire innovation chain: fundamental/applied research, incubation, transfer of technologies.
By transforming scientific knowledge into technologies, smart data and tools, LIST empowers citizens in their choices, public authorities in their decisions and businesses in their strategies.

Fabian Belin

Never miss an update from Fabian Belin

Create your free account on Innoget to connect with Fabian Belin and send them a request for information (RFI)

Fabian

Send a request for information
to Fabian

Send Message on Innoget

About Technology Offers

Technology Offers on Research Luxembourg are directly posted
and managed by its members as well as evaluation of requests for information. Research Luxembourg is the trusted open innovation and science network aimed at directly connect industry needs with professionals online.

Help

Need help requesting additional information or have questions regarding this Technology Offer?
Contact Research Luxembourg support